Skip to main content

Advertisement

SpringerLink
Log in

Comparative evaluation of efficacy of use of naftopidil and/or celecoxib for medical treatment of distal ureteral stones

  • Original Paper
  • Published:
Urolithiasis Aims and scope Submit manuscript

Abstract

We performed a randomized, prospective study to assess the possible role of combined a1D-receptor antagonist naftopidil and nonsteroidal anti-inflammatory hormones celecoxib for the spontaneous expulsion of distal ureteral stones. Patients were randomized to one of the three treatment groups. Treatment group 1 patients received naftopidil 50 mg/day, group 2 patients received naftopidil 50 mg/day plus celecoxib 200 mg (Take two capsules (400 mg) by mouth immediately, then take one capsule (200 mg) by mouth every 12 h), and group 3 patients received celecoxib 200 mg (Take two capsules (400 mg) by mouth immediately, then take one capsule (200 mg) by mouth every 12 h). All patients were instructed to drink at least 2 L of fluids daily. Pain descriptions were recorded by the patients using the visual analog scale. All patients were followed up for 2 weeks. A total of 105 patients provided consent and 103 patients completed the study. Stone expulsion was observed in 29 patients in group 1 (29 of 35, 82.86 %), 33 patients in group 2 (33 of 35, 94.29 %) and 20 patients in group 3 (20 of 33, 60.61 %). A statistically significant difference was noted with Chi-square testing for stone expulsion rate between groups 1 and 3, and groups 2 and 3 (P = 0.04 and P = 0.000, respectively). Kaplan–Meier curves were plotted to access the expulsion rate of each group over time. A significant difference was shown for the expulsion rate between the group 3 and the other two groups. (P < 0.001 by log-rank test).Average time to expulsion for groups 1, 2 and 3 was 8.00 ± 2.07, 7.70 ± 2.34 and 10.65 ± 2.92 days, respectively (P = 0.000). Treatment with naftopidil and celecoxib appears to be beneficial in distal ureter stone clearance, shortened the expulsion time, and could be used reliably and successfully to reduce the frequency and intensity of the pain episodes particularly.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Bensalah K, Pearle M, Lotan Y (2008) Cost-effectiveness of medical expulsive therapy using alpha-blockers for the treatment of distal ureteral stones. Eur Urol 53:411–419

    Article  PubMed  Google Scholar 

  2. De Sio M, Autorino R, Di Lorenzo G, Damiano R, Giordano D, Cosentino L (2006) Medical expulsive treatment of distal-ureteral stones using tamsulosin: a single-center experience. J Endourol 20:12–15

    Article  PubMed  Google Scholar 

  3. Seitz C, Liatsikos E, Porpiglia F, Tiselius HG, Zwergel U (2009) Medical therapy to facilitate the passage of stones: what is the evidence? Eur Urol 56(3):455–471

    Article  PubMed  Google Scholar 

  4. Porpiglia F, Ghignone G, Fiori C, Fontana D, Scarpa RM (2004) Nifedipine versus tamsulosin for the management of lower ureteral stones. J Urol 172:568–570

    Article  CAS  PubMed  Google Scholar 

  5. Dellabella M, Milanese G, Muzzonigro G (2005) Randomized trial of the efficacy of tamsulosin, nifedipine and phloroglucinol in medical expulsive therapy for distal ureteral calculi. J Urol 174:167–171

    Article  CAS  PubMed  Google Scholar 

  6. Singh A, Alter HJ, Littlepage A (2007) A systematic review of medical therapy to facilitate passage of ureteral calculi. Ann Emerg Med 50(5):552–563

    Article  PubMed  Google Scholar 

  7. Itoh Y, Kojima Y, Yasui T, Tozawa K, Sasaki S, Kohri K (2007) Examination of alpha 1 adrenoceptor subtypes in the human ureter. Int J Urol 14:749–753

    Article  CAS  PubMed  Google Scholar 

  8. Sigala S, Dellabella M, Milanese G et al (2004) Alpha-1 adrenoceptor subtypes in men juxtavesical ureters: molecular and pharmacological characterization. Eur Urol 3:119

    Article  Google Scholar 

  9. Cervenakov I, Fillo J, Mardiak J et al (2002) Speedy elimination of ureterolithiasis in lower part of ureters with the alpha-1blocker-tamsulosin. Int Urol Nephrol 34:25–29

    Article  CAS  PubMed  Google Scholar 

  10. Canda AE, Turna B, Cinar GM, Nazli O (2007) Physiology and pharmacology of the human ureter: basis for current and future treatments. Urol Int 78:289–298

    Article  PubMed  Google Scholar 

  11. Porpiglia F, Vaccino D, Billia M et al (2006) Corticosteroids and tamsulosin in the medical expulsive therapy for symptomatic distal ureter stones: single drug or association? Eur Urol 50:339–344

    Article  CAS  PubMed  Google Scholar 

  12. Sigala S, Dellabella M, Milanese G et al (2005) Evidence for the presence of a1 adrenoceptor subtypes in the human ureter. Neurourol Urodyn 24:142–148

    Article  CAS  PubMed  Google Scholar 

  13. Morita T, Wada I, Saeki H, Tsuchida S, Weiss RM (1987) Ureteral urine transport: changes in bolus volume, peristaltic frequency, intraluminal pressure and volume of flow resulting from autonomic drugs. J Urol 137:132–135

    CAS  PubMed  Google Scholar 

  14. Yilmaz E, Batislam E, Basar MM, Tuglu D, Ferhat M, Basar H (2005) The comparison and efficacy of 3 different alpha1-adrenergic blockers for distal ureteral stones. J Urol 713:2010–2012

    Article  Google Scholar 

  15. Wolf JS Jr (2007) Treatment selection and outcomes: ureteral calculi. Urol Clin N Am 34:409–410

    Article  Google Scholar 

  16. Wang CJ, Huang SW, Chang CH (2008) Efficacy of an a1 blocker in expulsive therapy of lower ureteral stones. J Endourol 22:41–42

    Article  PubMed  Google Scholar 

  17. Nishino Y, Masue T, Miwa K, Takahashi Y, Ishihara S, Deguchi T (2006) Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study. BJU Int 97:747–751

    Article  CAS  PubMed  Google Scholar 

  18. Sun XZ, He L, Ge WH, Lv JL (2009) Efficacy of selective alpha1D-blocker naftopidil as medical expulsive therapy for distal ureteral stones. J Urol 181:1716–1720

    Article  CAS  PubMed  Google Scholar 

  19. Zhou SG, Lu JL, Hui JH (2011) Comparing efficacy of a1Dreceptor antagonist naftopidil and a1A/D-receptor antagonist tamsulosin in management of distal ureteral stones. World J Urol 29:767–771

    Article  CAS  PubMed  Google Scholar 

  20. Lu JL, Tang QL, Liu FD et al (2012) Naftopidil and tolterodine in the medical expulsive therapy for intramural ureteral stones: a prospective randomized study. Urol Res 40:757–762

    Article  CAS  PubMed  Google Scholar 

  21. Hubner WA, Irby P, Stoller ML (1993) Natural history and current concepts for the treatment of small ureteral calculi. Eur Urol 24:172

    CAS  PubMed  Google Scholar 

  22. Ueno A, Kawamura T, Ogawa A, Takayasu H (1977) Relation of spontaneous passage of ureteral calculi to size. Urology 10:544

    Article  CAS  PubMed  Google Scholar 

  23. Coll DM, Varanelli MJ, Smith RC (2002) Relationship of spontaneous passage of ureteral calculi to stone size and location as revealed by unenhanced helical CT. AJR Am J Roentgenol 178:101

    Article  PubMed  Google Scholar 

  24. Shokeir AA (2001) Renal colic: pathophysiology, diagnosis and treatment. Eur Urol 39:241–249

    Article  CAS  PubMed  Google Scholar 

  25. Preminger GM, Tiselius HG, Assimos DG et al (2007) Guideline for the management of ureteral calculi. J Urol 178:2418–2434

    Article  PubMed  Google Scholar 

  26. Zwergel U, Zwergel T, Ziegler M (1991) Effects of prostaglandins and prostaglandin synthetase inhibitors on acutely obstructed kidneys in the dog. Urol Int 47:64–69

    Article  CAS  PubMed  Google Scholar 

  27. Fukuda S, Hamasaki Y, Tai H (1985) Increase in enzyme activities of prostaglandin biosynthesis and catabolism by acute ureteral ligation in rat kidney. Life Sci 37:1249–1255

    Article  CAS  PubMed  Google Scholar 

  28. Kallidonis P, Liourdi D, Liatsiko E (2011) Medical treatment for renal colic and stone expulsion. Eur Urol Supp l10:415–422

    Article  Google Scholar 

  29. Okegawa T (1983) Metabolic and cellular alterations underlying the exaggerated renal prostaglandin and thromboxane synthesis in ureter obstruction in rabbits. Inflammatory response involving fibroblasts and mononuclear cells. J Clin Invest 71:81–90

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  30. Ali M, Mohammed S (1986) Selective suppression of platelet thromboxane formation with sparing of vascular prostacyclin synthesis by aqueous extract of garlic in rabbits. Prostaglandins Leukot Med 25:139–146

    Article  CAS  PubMed  Google Scholar 

  31. Oosterlinck W, Philp NH, Charig C et al (1990) A double-blind single dose comparison of intramuscular ketorolac tromethamine and pethidine in the treatment of renal colic. J Clin Pharmacol 30:336–341

    Article  CAS  PubMed  Google Scholar 

  32. Porpiglia F, Destefanis P, Fiori C et al (2000) Effectiveness of nifedipine and deflazacort in the management of distal ureter stones. Urology 56:579–582

    Article  CAS  PubMed  Google Scholar 

  33. Borghi L, Meschi T, Amato F et al (1994) Nifedipine and methylprednisolone in facilitating ureteral stone passage: a randomized, double-blind, placebo-controlled study. J Urol 152:1095–1098

    CAS  PubMed  Google Scholar 

  34. Cooper J, Stack G, Cooper T (2000) Intensive medical management of ureteral calculi. Urology 56:575–578

    Article  CAS  PubMed  Google Scholar 

  35. Davidson M, Lang R (2000) Effects of selective inhibitors of cyclooxygenase- 1 (COX-1) and cyclooxygenase-2 (COX-2) on the spontaneous myogenic contractions in the upper urinary tract of the guinea pig and rat. Br J Pharmacol 129:661–670

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  36. Nakada S, Jerde T, Bjorling D et al (2000) Selective cyclooxygenase-2 inhibitors reduce ureteral contraction in vitro: a better alternative for renal colic? J Urol 163:607–612

    Article  CAS  PubMed  Google Scholar 

  37. Mastrangelo D, Wisard M, Rohner S, Leisinger H et al (2000) Diclofenac and NS-398, a selective cyclooxygenase-2 inhibitor, decrease agonist induced contractions of the pig isolated ureter. Urol Res 28:376–382

    Article  CAS  PubMed  Google Scholar 

  38. LaerumE Ommundsen OE, Granseth JE, Christiansen A et al (1995) Oral diclofenac in the prophylactic treatment of recurrent renal colic: a double-blind comparison with placebo. Eur Urol 28:108–111

    Google Scholar 

  39. Phillips E, Hinck B, Pedro R (2009) Celecoxib in the management of acute renal colic: a randomized controlled clinical trial. Urology 74:994–999

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

There is no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Urology, Affiliated Jiangning Hospital, Nanjing Medical University, gushan Road 78, Nanjing, 211100, China

    Jian Lin Lv & Qing Lai Tang

Authors
  1. Jian Lin Lv
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Qing Lai Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jian Lin Lv.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lv, J.L., Tang, Q.L. Comparative evaluation of efficacy of use of naftopidil and/or celecoxib for medical treatment of distal ureteral stones. Urolithiasis 42, 541–547 (2014). https://doi.org/10.1007/s00240-014-0708-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00240-014-0708-6

Keywords

Search

Navigation